JP2013533883A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533883A5
JP2013533883A5 JP2013518684A JP2013518684A JP2013533883A5 JP 2013533883 A5 JP2013533883 A5 JP 2013533883A5 JP 2013518684 A JP2013518684 A JP 2013518684A JP 2013518684 A JP2013518684 A JP 2013518684A JP 2013533883 A5 JP2013533883 A5 JP 2013533883A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
halo
substituted
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013518684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013533883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042506 external-priority patent/WO2012003264A1/en
Publication of JP2013533883A publication Critical patent/JP2013533883A/ja
Publication of JP2013533883A5 publication Critical patent/JP2013533883A5/ja
Withdrawn legal-status Critical Current

Links

JP2013518684A 2010-06-30 2011-06-30 PI3Kδ阻害剤としての含窒素複素環化合物 Withdrawn JP2013533883A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36000110P 2010-06-30 2010-06-30
US61/360,001 2010-06-30
PCT/US2011/042506 WO2012003264A1 (en) 2010-06-30 2011-06-30 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors

Publications (2)

Publication Number Publication Date
JP2013533883A JP2013533883A (ja) 2013-08-29
JP2013533883A5 true JP2013533883A5 (OSRAM) 2014-08-14

Family

ID=44454536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518684A Withdrawn JP2013533883A (ja) 2010-06-30 2011-06-30 PI3Kδ阻害剤としての含窒素複素環化合物

Country Status (7)

Country Link
US (1) US20130079342A1 (OSRAM)
EP (1) EP2588473A1 (OSRAM)
JP (1) JP2013533883A (OSRAM)
AU (1) AU2011271462A1 (OSRAM)
CA (1) CA2803620A1 (OSRAM)
MX (1) MX2012015143A (OSRAM)
WO (1) WO2012003264A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104870017B (zh) 2012-11-08 2020-08-14 理森制药股份公司 含有PDE4抑制剂和PI3δ或双重PI3δ-γ激酶抑制剂的药物组合物
KR20150082613A (ko) * 2012-11-16 2015-07-15 머크 샤프 앤드 돔 코포레이션 인간 포스파티딜이노시톨 3-키나제 델타의 퓨린 억제제
CN104918940B (zh) * 2012-11-16 2017-03-08 默沙东公司 人磷脂酰肌醇3‑激酶δ的嘌呤抑制剂
US9944639B2 (en) 2014-07-04 2018-04-17 Lupin Limited Quinolizinone derivatives as PI3K inhibitors
MA40957A (fr) * 2014-10-09 2017-09-19 Biomarin Pharm Inc Inhibiteurs de biosynthèse d'héparane sulfate pour traiter des maladies
EP3359526A4 (en) 2015-10-05 2019-04-03 The Trustees of Columbia University in the City of New York ACTIVATORS OF AUTOPHAGIC RIVER AND PHOSPHOLIPASE D AND PURIFICATION OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
WO2020097398A1 (en) 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
KR20220087497A (ko) 2019-10-18 2022-06-24 더 리전츠 오브 더 유니버시티 오브 캘리포니아 병원성 혈관을 표적화하기 위한 화합물 및 방법
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CA3181537A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
WO2022140527A1 (en) 2020-12-23 2022-06-30 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
CA3234638A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
TW202325289A (zh) 2021-11-09 2023-07-01 美商雅捷可斯治療公司 Jak2抑制劑之形式及組合物
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
DE3020458C2 (de) 1980-05-29 1986-07-31 Herzog, Thomas, Prof. Dr., 3500 Kassel Vorgehängte Fassaden-, Bau- oder Dekorationsplatte
WO1992017452A1 (en) * 1991-04-03 1992-10-15 Korea Research Institute Of Chemical Technology 2-quinolinone derivatives
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
GB9611460D0 (en) 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
US5858753A (en) 1996-11-25 1999-01-12 Icos Corporation Lipid kinase
US5822910A (en) 1997-10-02 1998-10-20 Shewmake; I. W. Fishing line tensioning device
WO2004108704A1 (en) * 2003-06-05 2004-12-16 Astrazeneca Ab Pyrimidin-4-yl 3-cyanoquinoline derivatives for use in the treatment of tumours
WO2004108703A1 (en) * 2003-06-05 2004-12-16 Astrazeneca Ab Pyrazinyl 3-cyanoquinoline derivatives for use in the treatment of tumours
TW200529846A (en) * 2004-02-20 2005-09-16 Wyeth Corp 3-quinolinecarbonitrile protein kinase inhibitors
US7705018B2 (en) * 2007-03-23 2010-04-27 Amgen Inc. Substituted quinolines and their uses in treatment of inflammatory and related conditions
AU2008231304B2 (en) * 2007-03-23 2011-05-12 Amgen Inc. Heterocyclic compounds and their uses
EP2231641B1 (en) * 2007-12-21 2016-06-01 UCB Biopharma SPRL Quinoxaline and quinoline derivatives as kinase inhibitors
WO2010151791A1 (en) * 2009-06-25 2010-12-29 Amgen Inc. Heterocyclic compounds and their uses
EA201270013A1 (ru) * 2009-06-25 2012-06-29 Амген Инк. Гетероциклические соединения и их применение
US8957090B2 (en) * 2009-11-12 2015-02-17 Ucb Pharma S.A. Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
PH12013501489A1 (en) * 2010-12-17 2013-08-28 Hoffmann La Roche Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2013533883A5 (OSRAM)
JP2013530236A5 (OSRAM)
JP2013533884A5 (OSRAM)
JP2013530238A5 (OSRAM)
JP2016530259A5 (OSRAM)
JP2013531031A5 (OSRAM)
JP2016518385A5 (OSRAM)
JP2019527203A5 (OSRAM)
JP2015501833A5 (OSRAM)
JP2019524883A5 (OSRAM)
JP2017508789A5 (OSRAM)
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
JP2015527401A5 (OSRAM)
JP2016540742A5 (OSRAM)
JP2016510758A5 (OSRAM)
RU2016137678A (ru) Соединения с эфирными группами для лечения опосредованных комплементом нарушений
JP2013542996A5 (OSRAM)
JP2015504067A5 (OSRAM)
JP2016531868A5 (OSRAM)
HRP20140147T1 (hr) 3-supstituirani derivati hinolina ili hinoksalina i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze (pi3k)
JP2016531858A5 (OSRAM)
JP2013522316A5 (OSRAM)
JP2013530239A5 (OSRAM)
JP2015500842A5 (OSRAM)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина